Diabetes Research and Clinical Practice
Volume 74 , Pages S104-S107 , December 2006

Acute complications of insulin pump therapy

  • Bruno Guerci

      Affiliations

    • Corresponding Author InformationCorresponding author. Address for correspondence: Professor Bruno Guerci, MD, PhD, Service de Diabetologie, Maladies Métaboliques & Maladies de la Nutrition, Hôpital Jeanne d'Arc, CIC/INSERM CHU Nancy, 54201 Toul cedex BP 303, France. Tel.: +33 3 8365 6528; Fax: +33 3 8365 6600

References 

  1. Adverse events and their association with treatment regimens in the diabetes control and complications trial . Diabetes Care . 1995;18:1415–1427
  2. Binder C , Lauritzen T , Faber O , Pramming S . Insulin pharmacokinetics . Diabetes Care . 1984;7:188–199
  3. Egger M , Davey Smith G , Stettler C , Diem P . Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis . Diabet Med . 1997;14:919–928
  4. Brange J , Owens DR , Kang S , Volund A . Monomeric insulins and their experimental and clinical implications . Diabetes Care . 1990;13:923–954
  5. Guerci B , Meyer L , Salle A , Charrie A , Dousset B , Ziegler O , et al.   Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients . J Clin Endocrinol Metab . 1999;84:2673–2678
  6. Melki V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, et al  Improvement of HbAlc and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps . Diabetes Care . 1998;21:977–982
  7. Bode BW , Steed RD , Davidson PC . Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes . Diabetes Care . 1996;19:324–327
  8. Retnakaran R , Hochman J , DeVries JH , Hanaire-Broutin H , Heine RJ , Melki V , et al.   Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline Alc . Diabetes Care . 2004;27:2590–2596
  9. Lepore M , Pampanelli S , Fanelli C , Porcellati F , Bartocci L , Di Vincenzo A , et al.   Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro . Diabetes . 2000;49:2142–2148
  10. Doyle EA , Weinzimer SA , Steffen AT , Ahern JA , Vincent M , Tamborlane WA . A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine . Diabetes Care . 2004;27:1554–1558

PII: S0168-8227(06)70009-2

doi: 10.1016/S0168-8227(06)70009-2

Diabetes Research and Clinical Practice
Volume 74 , Pages S104-S107 , December 2006

Article Tools